Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - Swiss National Clinical Registry TREATswitzerland
Status: Recruiting
Location: See all (9) locations...
Study Type: Observational
SUMMARY
As structured and detailed data on the management of AD, a common chronic inflammatory skin disease which has a high impact on patients' quality of life and socioeconomic burden, are not available in Switzerland, the planned registry will overcome this gap. It will provide data on the medical care of patients with AD for health care research and allow to study the efficacy and safety of approved and available therapies for AD in daily life.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
View:
• Age ≥ 12 years
• AD according to the UK Working Party's Diagnostic Criteria (28)
• Moderate to severe AD as defined by
• objective SCORAD \> 20 or IGA ≥ 3 (moderate) or
• currently on systemic antiinflammatory therapy for AD or
• previous systemic antiinflammatory therapy for AD within past 24 months
Locations
Other Locations
Switzerland
Universitätsspital Basel, Allergologie
RECRUITING
Basel
Inselspital, Department of Dermatology
RECRUITING
Bern
Dermatology & Skin Care Clinic
RECRUITING
Buochs
HFR Hôpital Cantonal de Fribourg
RECRUITING
Fribourg
Dermatologie CHUV
RECRUITING
Lausanne
Luzerner Kantonsspital, Zentrum für Dermatologie und Allergologie
NOT_YET_RECRUITING
Lucerne
Kantonsspital St. Gallen - Klinik für Dermatologie, Venerologie und Allergologie
RECRUITING
Sankt Gallen
PLAZA Kliniken
RECRUITING
Uster
Institut für Dermatologie und Venerologie Stadtspital Zürich Europaallee
RECRUITING
Zurich
Contact Information
Primary
Dagmar Simon, Prof. Dr. med.
dagmar.simon@insel.ch
+41 31 632 22 78
Time Frame
Start Date: 2022-06-02
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 700
Related Therapeutic Areas
Sponsors
Leads: Swiss Society of Dermatology and Venereology